Aug 24, 2022 | In the News
The FDA is anticipated to approve psilocybin as a therapeutic drug to treat depression within the next two years. This news comes from an official letter sent by the Substance Abuse and Mental Health Services Administration. The letter has many interesting statements,...
Aug 22, 2022 | Legal Update
Utah’s Mental Illness Psychotherapy Drug Task Force is active and operating, but what is it? What is the task force doing? Who is on the task force, and why was it formed in the first place? You can find the answers to all of these questions below as we take a closer...
Aug 17, 2022 | Legal Update
Utah HB 167 is a House Bill that established the Mental Illness Psychotherapy Drug Task Force. HB 167 was first introduced in January, by Rep. Brady Brammer, where it passed both chambers of the legislature. The bill garnered almost unanimous support on both sides of...